FdaApplication
NDA 018965
Identifiers
- fda_app_no: NDA018965
Properties
| Property | Value |
|---|---|
| applicant_name | ATNAHS PHARMA US LTD |
| application_type | NDA |
| approval_date | 1987-03-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROSYN | NAPROXEN | 25MG/ML | SUSPENSION;ORAL |
1 product